Eiichi Imano
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Growth Hormone and Insulin-like Growth Factors
- Hepatology top 5%
Papers in
-
- Metabolism, Diabetes, and Cancer 6
- Nuclear Structure and Function 2
-
- Diabetes Treatment and Management 3
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Co-authors
- Yoshimitsu Yamasaki (10 shared papers)Yoshitaka Kajimoto (4 shared papers)Tsutomu Kanda (9 shared papers)Ryuzo Kawamori (11 shared papers)Norimichi Iwama (5 shared papers)Yutaka Umayahara (2 shared papers)Tomoari Kamada (4 shared papers)Toyohiko Morishima (3 shared papers)
- Journals
- Journal of Hepatology (2 papers)Diabetologia (2 papers)Biochemical and Biophysical Research Communications (2 papers)Diabetes Research and Clinical Practice (2 papers)Journal of Pharmacy and Pharmacology (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Eiichi Imano
23 papers receiving 944 citations
Peers
Comparison fields: 5 of 83
- Endocrinology, Diabetes and Metabolism 354
- Hepatology 130
- Genetics 307
- Nephrology 46
- Molecular Biology 433
Countries citing papers authored by Eiichi Imano
This map shows the geographic impact of Eiichi Imano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Imano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Imano more than expected).
Fields of papers citing papers by Eiichi Imano
This network shows the impact of papers produced by Eiichi Imano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Imano. The network helps show where Eiichi Imano may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiichi Imano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 300 | |
| 2 | 1998 | 174 | |
| 3 | 2005 | 116 | |
| 4 | 2005 | 93 | |
| 5 | 1998 | 51 | |
| 6 | 1991 | 41 | |
| 7 | 1991 | 36 | |
| 8 | 1999 | 33 | |
| 9 | 1992 | 20 | |
| 10 | 2007 | 18 | |
| 11 | 2001 | 16 | |
| 12 | 1991 | 16 | |
| 13 | 1991 | 12 | |
| 14 | 1994 | 11 | |
| 15 | 1993 | 10 | |
| 16 | 1987 | 8 | |
| 17 | 1990 | 5 | |
| 18 | 1996 | 4 | |
| 19 | The Usefulness of Combination Therapy with Preprandial Rapid-Acting Insulin Injections and .ALPHA.-Glucosidase Inhibitor in non-obese NIDDM Patients with Secondary Failure on Oral Hypoglycemic Agents. | 1996 | 2 |
| 20 | 1989 | 2 |
About Eiichi Imano
Eiichi Imano is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Genetics, Cardiology and Cardiovascular Medicine and Surgery, having authored 23 papers that have together received 973 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (6 papers), Pancreatic function and diabetes (3 papers), Diabetes and associated disorders (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Diabetes Treatment and Management (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Nuclear Structure and Function (2 papers) and Cardiovascular Health and Disease Prevention (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (354 citations), Hepatology (130 citations), Genetics (307 citations), Nephrology (46 citations) and Molecular Biology (433 citations). Eiichi Imano has collaborated with scholars based in Japan and United States. Frequent co-authors include Yoshimitsu Yamasaki, Yoshitaka Kajimoto, Tsutomu Kanda, Ryuzo Kawamori, Norimichi Iwama, Yutaka Umayahara, Tomoari Kamada, Toyohiko Morishima, Hirotaka Watada and Masatsugu Hori. Their work appears in journals such as Journal of Hepatology, Diabetologia, Biochemical and Biophysical Research Communications, Diabetes Research and Clinical Practice and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.